MMP inhibitor Prinomastat, Purity ≥98%

Synonym: 192329-42-3; MMP inhibitor; AG3340; AG 3340;AG-3340; KB-R9896; KBR9896; KB R9896

CAS Number: 192329-42-3
Compound CID: 466151

Product Size

1 mg; 5 mg; 10 mg; 50 mg

Price

Datasheet

MSDS

Properties

Description

Prinomastat inhibits MMPs, enzymes that degrade extracellular matrix components, thus having potential therapeutic applications in cancer and chronic inflammatory diseases. It targets MMP-1, MMP-2, MMP-3, MMP-3, MMP-9, and MMP-9.

Molecular Weight

423.51

Molecular Formula

C₁₈H₂₁N₃O₅S₂

Targets

MMP-1: 79 nM; MMP-2: 0.05 nM (Ki); MMP-3: 6..3 nM; MMP-3: 0.3 nM (Ki); MMP-9: 5 nM; MMP-9: 0.26 nM (Ki)

Form

Lyophilized powder

Purity

Identity

Confirmed by NMR/HPLC/MS.

Applications

Prinomastat is used in cancer research to inhibit Matrix Metalloproteinases (MMPs), which are involved in the degradation of the extracellular matrix and tumor metastasis.